The FDA has updated the labels for all GLP-1 receptor agonists, including popular medications Ozempic, Wegovy, Saxenda and Mounjaro, to include a new warning about the risk of pulmonary aspiration ...

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

Stroke was the fourth leading cause of death in the US last year, accounting for 162,600 deaths, according to preliminary data.

Originally intended as a treatment for diabetes, GLP-1 drugs like Ozempic could be set to turn the food and drink industry ...

You can’t go far lately without seeing news and social media coverage of GLP-1 (glucagon-like peptide-1) receptor agonists ...

MONDAY, Nov. 11, 2024 (HealthDay News) -- The weight-loss drug Ozempic can help reduce stroke patients’ risk of a heart ...

Branded GLP-1 drugs such as Ozempic and Wegovy are becoming more widely available after over two years on the Food and Drug Administration's shortage list. The FDA authorizes compounding of ...

NIB has backed weight-loss drugs like Ozempic, as the next "wonder drug", saying millions of people will be taking them ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 ...

Lexaria Bioscience (LEXX) provides the following glucagon-like peptide-1 industry update. It is no surprise that Novo Nordisk’s ...

The new menu includes five smoothies “created to assist the millions of Americans currently taking prescription GLP-1 medications" Smoothie King; George Frey/Bloomberg via Getty Smoothie King has a ...